Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission: A National Multi-center, Double Blinded, Randomized, Placebo Controlled Study
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms STOP IT
- 07 Jun 2017 Biomarkers information updated
- 17 Oct 2015 Planned number of patients changed from 139 to 136, as reported by European Clinical Trials Database.
- 08 Jun 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2012-002702-51).